<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Seventeen patients with <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> or <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> received demeclocycline as treatment for <z:hpo ids='HP_0002902'>hyponatremia</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Prior to demeclocycline therapy no patients showed clinical signs of <z:e sem="disease" ids="C0546817" disease_type="Disease or Syndrome" abbrv="">fluid overload</z:e> or saline <z:mpath ids='MPATH_63'>depletion</z:mpath> </plain></SENT>
<SENT sid="2" pm="."><plain>In <z:hpo ids='HP_0000001'>all</z:hpo> patients inappropriately concentrated urine (mean urine osmolality = 548 mOSM/kg <z:chebi fb="2" ids="29375,33813">H2O</z:chebi>) or increased urine content of <z:chebi fb="199" ids="26708">sodium</z:chebi> (mean urine <z:chebi fb="199" ids="26708">sodium</z:chebi> = 91 mEq/L) were documented prior to demeclocycline therapy </plain></SENT>
<SENT sid="3" pm="."><plain>No patient had developed <z:hpo ids='HP_0002902'>hyponatremia</z:hpo> in association with <z:chebi fb="0" ids="35610">antineoplastic drug</z:chebi> therapy </plain></SENT>
<SENT sid="4" pm="."><plain>The average serum <z:chebi fb="199" ids="26708">sodium</z:chebi> (NaS) at the time of initiation of therapy was 121 mEq/L </plain></SENT>
<SENT sid="5" pm="."><plain>NaS increased in <z:hpo ids='HP_0000001'>all</z:hpo> patients despite the simultaneous administration of generous volumes of fluid </plain></SENT>
<SENT sid="6" pm="."><plain>NaS exceeded 130 mEq/L and average of 3.5 days following institution of demeclocycline </plain></SENT>
<SENT sid="7" pm="."><plain>Patients lost an average of 2.3 kg during demeclocycline </plain></SENT>
<SENT sid="8" pm="."><plain>The toxicity noted following demeclocycline was <z:hpo ids='HP_0002157'>azotemia</z:hpo> and <z:hpo ids='HP_0003259'>increased serum creatinine</z:hpo> </plain></SENT>
<SENT sid="9" pm="."><plain>Eight patients developed serum <z:chebi fb="20" ids="16199">urea</z:chebi> nitrogen (SUN) in excess of 25 mg/dl; average maximum <z:chebi fb="0" ids="16737">creatinine</z:chebi> in these eight patients was 1.9 mg/dl </plain></SENT>
<SENT sid="10" pm="."><plain>Average peak <z:chebi fb="0" ids="16737">creatinine</z:chebi> in eight patients who did not develop <z:hpo ids='HP_0002157'>azotemia</z:hpo> was 0.87 mg/dl </plain></SENT>
<SENT sid="11" pm="."><plain><z:hpo ids='HP_0002157'>Azotemia</z:hpo> seemed to be correlated with simultaneous administration of other <z:chebi fb="0" ids="50909">nephrotoxic agents</z:chebi> and with administration of higher doses (1200 mg/day) of demeclocycline </plain></SENT>
</text></document>